DNA repair gene expression levels in NSCLC patients treated with platinum based chemotherapy: an open label randomized phase II study.

Trial Profile

DNA repair gene expression levels in NSCLC patients treated with platinum based chemotherapy: an open label randomized phase II study.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2011

At a glance

  • Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gemcitabine (Primary)
  • Indications Non-small cell lung cancer
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms GENE-REPAIR
  • Most Recent Events

    • 03 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top